×
Entrez Id:
43
Gene Symbol:
ACHE
ACHE
0.300
Therapeutic
phenotype
CTD_human
HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants.
27083141
2016
×
Entrez Id:
111
Gene Symbol:
ADCY5
ADCY5
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
126
Gene Symbol:
ADH1C
ADH1C
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
135
Gene Symbol:
ADORA2A
ADORA2A
0.300
Biomarker
phenotype
CTD_human
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
16780890
2006
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Therapeutic
phenotype
CTD_human
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
9151294
1997
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Biomarker
phenotype
CTD_human
Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
7902979
1993
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Therapeutic
phenotype
CTD_human
Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.
190674
1977
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Biomarker
phenotype
CTD_human
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
9151294
1997
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Therapeutic
phenotype
CTD_human
Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
7902979
1993
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Biomarker
phenotype
CTD_human
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
8102213
1993
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Therapeutic
phenotype
CTD_human
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
8102213
1993
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Biomarker
phenotype
CTD_human
Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.
190674
1977
×
Entrez Id:
478
Gene Symbol:
ATP1A3
ATP1A3
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
10159
Gene Symbol:
ATP6AP2
ATP6AP2
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
538
Gene Symbol:
ATP7A
ATP7A
0.300
Biomarker
phenotype
CTD_human
Prenatal treatment of mosaic mice (Atp7a mo-ms) mouse model for Menkes disease, with copper combined by dimethyldithiocarbamate (DMDTC).
22815746
2012
×
Entrez Id:
6311
Gene Symbol:
ATXN2
ATXN2
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
6315
Gene Symbol:
ATXN8OS
ATXN8OS
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
203228
Gene Symbol:
C9orf72
C9orf72
0.010
Biomarker
phenotype
BEFREE
C9orf72 -associated parkinsonism predominantly consisted in a hypokinetic-rigid syndrome without resting tremor (61%), with both asymmetric (59%) and symmetric (41%) distributions.
26810719
2016
×
Entrez Id:
8913
Gene Symbol:
CACNA1G
CACNA1G
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
51142
Gene Symbol:
CHCHD2
CHCHD2
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
1132
Gene Symbol:
CHRM4
CHRM4
0.300
Biomarker
phenotype
CTD_human
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
9920179
1999
×
Entrez Id:
27235
Gene Symbol:
COQ2
COQ2
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
1565
Gene Symbol:
CYP2D6
CYP2D6
0.300
Biomarker
phenotype
CTD_human
Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy.
15570195
2004
×
Entrez Id:
23317
Gene Symbol:
DNAJC13
DNAJC13
0.100
Biomarker
phenotype
HPO
×
Entrez Id:
9829
Gene Symbol:
DNAJC6
DNAJC6
0.100
Biomarker
phenotype
HPO